Patent ID: 7833991
Filing Date: 2010-11-16
Classification: A61P,C07D

Abstract:
1. A compound represented by the following general formula (1), a pharmacologically acceptable salt thereof, or a prodrug thereof: wherein each of n each of R A A W is a phenylene group or a naphthylene group; X is —(C═O)—, CH D is a group represented by the following formula (6): wherein Q is C═O when X is NH, or NR Y is —(CH wherein each of m z is a phenylene group; and B is —NR wherein each of R wherein one or two or more asymmetric carbon atoms may exist in the compound represented by the general formula (1), where when one asymmetric carbon atom exists, the compound may be in the form of any one of a pure optically active substance represented by the absolute configuration R or S, a mixture thereof in a predetermined ratio, and a racemic mixture thereof or when two or more asymmetric carbon atoms exist, the compound may be in the form of any one of an optically pure diastereomer, a racemic mixture thereof, and a combination thereof in a predetermined ratio, and wherein said prodrug is formed by attachment of an alkoxycarbonyl group or a dialkylaminosulfone group to a nitrogen in an imidazole ring of a compound of general formula (I).